Mouwasat Medical Services Company (4002.SE)

Also known as:  Mouwasat
Data delayed by 15 minutes
191.40 SAR 4.402.35%
As of 03 AUG 2021 11:55 GMT|Saudi SE

Mouwasat Stock Price & Performance Powered By Knowledge Direct

Recommendation
-
Div Yield
-
P/E (Last 12 Month)
32.79
Upside
-
Target Price (Mean)
-
52Wk
133.0 03 JAN
202.0 17 MAY

Open
187.20 SAR
Previous Close
187.00 SAR
Turnover
19.67M SAR
EPS
5.673 SAR
Volume
103,294
Transactions
1423
Market Cap
18.70B SAR
IPO Date
02-Sep-2009
Analyst Recommendation
Sell
Hold
Buy
Analyst Rating
Strong Buy
Buy
Hold
Sell
Strong Sell

About Mouwasat Medical Services CompanyLast updated on: 28 March 2020

Business Summary
Ownership and operation of hospitals, clinics, medical centers and pharmacies.
Country of Incorporation
Ownership Type
Established In
1997
Primary Sector
Stock Listing
IDStock TypeCurrencyExchangeSymbol
4002.SSEOrdinarySARSaudi SE4002

Contact details

Primary address
Building: Mouwasat Medical Services Company, Block 71
Street: King Fahad Road
Area: Uhod District
P.O. Box: 282
Country: Saudi Arabia
City: Dammam
City Suffix: 31411
CONTACT
Region
Eastern Province
More
All Press Releases

A rite of passage for lebanon's future pharmacists

Recently, the PGY1 residency program obtained a four-year accreditation from the American Society of Health-System Pharmacists (ASHP) ­- with retroactive effect from 2019 when residents first enrolled - placing it on a par with residencies in the US

Press Release - Tuesday 3 August 2021
All Health Care News
All Markets News

Ownership

Revenue
Net Income
Profit Margin
Total Assets
Total Liabilities
Debt to Assets
Operating
Investing
Financing

Executives

Mr Naser Sultan Fahad Al Subaie
Chief Executive Officer
Mr Mohammed Bin Suleiman Mohammed Al Saleem
Managing Director
Mr Khalid Bin Suleiman Mohammed Al Saleem
Deputy Managing Director

Board Members

Mr Mohammed Sultan Hamad Al Subaie
Chairman
Mr Naser Sultan Fahad Al Subaie
Vice Chairman
Mr Mohammed Bin Suleiman Mohammed Al Saleem
Director
More

Company information provided by Refinitiv

Refinitiv research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).

Peers

StocksLast Price% Change
PHARMACEUTICALS57.900 SAR-2.03
SAUDI GERMAN HSP38.350 SAR-0.13
AL HAMMADI CO40.300 SAR-1.35
SULAIMAN ALHABIB177.400 SAR1.95
DALLAH HEALTH76.900 SAR0.92
More

Tuesday Outlook: Asian shares slip as Delta virus spreads; dollar on back foot

Tuesday Outlook: Asian shares slip as Delta virus spreads; dollar on back foot

Rising concerns about the Delta variant prompt traders to wind back bets on strong economic recovery

More

Most Viewed Stocks

Stock Screener

More